Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for iRhythm Holdings, Inc. (IRTC : NSDQ)
 
 • Company Description   
IRHYTHM HLDGS is a digital health care company which creates trusted solutions that detect, predict and prevent disease. IRHYTHM HLDGS, formerly known as iRhythm Technologies Inc., is based in SAN FRANCISCO.

Number of Employees: 2,400

 
 • Price / Volume Information   
Yesterday's Closing Price: $116.56 Daily Weekly Monthly
20 Day Moving Average: 580,839 shares
Shares Outstanding: 32.86 (millions)
Market Capitalization: $3,830.39 (millions)
Beta: 1.33
52 Week High: $212.00
52 Week Low: $108.81
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.03% -8.72%
12 Week -16.85% -23.13%
Year To Date -34.31% -38.93%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
699 8TH STREET SUITE 600
-
San Francisco,CA 94103
USA		 ph: 415-632-5700
fax: -		 investors@irhythmtech.com http://www.irhythmtech.com
 
 • General Corporate Information   
Officers
Quentin S. Blackford - Chief Executive Officer and President
Abhijit Y. Talwalkar - Chairman
Daniel Wilson - Chief Financial Officer
Marc Rosenbaum - Chief Accounting Officer
Bruce G. Bodaken - Director

Peer Information
iRhythm Holdings, Inc. (HLIS)
iRhythm Holdings, Inc. (AZTA)
iRhythm Holdings, Inc. (APYI)
iRhythm Holdings, Inc. (RNVA)
iRhythm Holdings, Inc. (HMSY)
iRhythm Holdings, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 450056106
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 07/30/26
Share - Related Items
Shares Outstanding: 32.86
Most Recent Split Date: (:1)
Beta: 1.33
Market Capitalization: $3,830.39 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.13 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/30/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 879.70
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 23.76
Price/Cash Flow: -
Price / Sales: 4.86
EPS Growth
vs. Year Ago Period: 63.16%
vs. Previous Quarter: -220.69%
Sales Growth
vs. Year Ago Period: 25.66%
vs. Previous Quarter: -4.55%
ROE
03/31/26 - -10.26
12/31/25 - -28.15
09/30/25 - -41.86
ROA
03/31/26 - -1.39
12/31/25 - -3.35
09/30/25 - -4.42
Current Ratio
03/31/26 - 5.17
12/31/25 - 4.63
09/30/25 - 4.63
Quick Ratio
03/31/26 - 4.98
12/31/25 - 4.48
09/30/25 - 4.50
Operating Margin
03/31/26 - -1.76
12/31/25 - -4.38
09/30/25 - -6.00
Net Margin
03/31/26 - -3.53
12/31/25 - -5.96
09/30/25 - -7.32
Pre-Tax Margin
03/31/26 - -3.43
12/31/25 - -5.84
09/30/25 - -7.23
Book Value
03/31/26 - 4.91
12/31/25 - 4.74
09/30/25 - 3.78
Inventory Turnover
03/31/26 - 10.96
12/31/25 - 11.90
09/30/25 - 12.56
Debt-to-Equity
03/31/26 - 4.03
12/31/25 - 4.25
09/30/25 - 5.32
Debt-to-Capital
03/31/26 - 80.14
12/31/25 - 80.96
09/30/25 - 84.18
 

Powered by Zacks Investment Research ©